Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Feugier

Showing results (1-10 of 164) with videos related to

Pageof 17
Sort By:
Future Oncology (London, England)|May 9, 2015
A review of rituximab, the first anti-CD20 monoclonal antibody used in the treatment of B non-Hodgkin's lymphomasPierre Feugier
La Revue Du Praticien|April 2, 2011
[Superficial adenopathy]Pierre Feugier, Aurore Perrot
F1000Research|March 26, 2019
Recent advances in the first-line treatment of follicular non-Hodgkin lymphomaPierre Feugier, Lauriane Filliatre-Clement
Current Opinion in Oncology|July 9, 2015
Management of elderly patients with chronic lymphocytic leukemia in the era of targeted therapiesLoïc Ysebaert, Pierre Feugier, Anne-Sophie Michallet
Blood Cells, Molecules & Diseases|February 11, 2011
Polymorphonuclear neutrophils from JAK2(V617F) positive MPD patients do not support hypercoagulability: A study with calibrated automated thrombography (CAT)Julien Perrin, Dana Ranta, Fabienne Empereur, et al.
American Journal of Hematology|November 4, 2015
Amyl nitrite inhalation, a "volatile" anemiaLauriane Filliatre, Julien Broséus, Serge Pissard, et al.
Haematologica|September 5, 2007
Expression of functional toll-like receptors by B-chronic lymphocytic leukemia cellsCindy Grandjenette, Anne Kennel, Gilbert C Faure, et al.
British Journal of Haematology|September 21, 2006
Daclizumab, an efficient treatment for steroid-refractory acute graft-versus-host diseasePierre Bordigoni, Sophie Dimicoli, Laurence Clement, et al.
Leukemia & Lymphoma|October 1, 2011
Active Toll-like receptor-7 triggering of chronic lymphocytic leukemia B-cells by imiquimodMin Chen, Marcelo de Carvalho Bittencourt, Pierre Feugier, et al.
Journal of Clinical Medicine|August 7, 2021
Patients with Persistent Polyclonal B-Cell Lymphocytosis Share the Symptomatic Criteria of Systemic Exertion Intolerance DiseaseRomain Morizot, Jean-Dominique de Korwin, Pierre Feugier, et al.
Pageof 17

Showing results (1-10 of 164) with videos related to

Sort By:
Pageof 17
Future Oncology (London, England)|May 9, 2015
A review of rituximab, the first anti-CD20 monoclonal antibody used in the treatment of B non-Hodgkin's lymphomasPierre Feugier
La Revue Du Praticien|April 2, 2011
[Superficial adenopathy]Pierre Feugier, Aurore Perrot
F1000Research|March 26, 2019
Recent advances in the first-line treatment of follicular non-Hodgkin lymphomaPierre Feugier, Lauriane Filliatre-Clement
Current Opinion in Oncology|July 9, 2015
Management of elderly patients with chronic lymphocytic leukemia in the era of targeted therapiesLoïc Ysebaert, Pierre Feugier, Anne-Sophie Michallet
Blood Cells, Molecules & Diseases|February 11, 2011
Polymorphonuclear neutrophils from JAK2(V617F) positive MPD patients do not support hypercoagulability: A study with calibrated automated thrombography (CAT)Julien Perrin, Dana Ranta, Fabienne Empereur, et al.
American Journal of Hematology|November 4, 2015
Amyl nitrite inhalation, a "volatile" anemiaLauriane Filliatre, Julien Broséus, Serge Pissard, et al.
Haematologica|September 5, 2007
Expression of functional toll-like receptors by B-chronic lymphocytic leukemia cellsCindy Grandjenette, Anne Kennel, Gilbert C Faure, et al.
British Journal of Haematology|September 21, 2006
Daclizumab, an efficient treatment for steroid-refractory acute graft-versus-host diseasePierre Bordigoni, Sophie Dimicoli, Laurence Clement, et al.
Leukemia & Lymphoma|October 1, 2011
Active Toll-like receptor-7 triggering of chronic lymphocytic leukemia B-cells by imiquimodMin Chen, Marcelo de Carvalho Bittencourt, Pierre Feugier, et al.
Journal of Clinical Medicine|August 7, 2021
Patients with Persistent Polyclonal B-Cell Lymphocytosis Share the Symptomatic Criteria of Systemic Exertion Intolerance DiseaseRomain Morizot, Jean-Dominique de Korwin, Pierre Feugier, et al.
Pageof 17